Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Actelion top pay no vote highlights time lag

This article was originally published in Scrip

Executive Summary

That a company's board of directors may well be at odds with its shareholders, particularly when it comes to the pay packages of its executives and directors, has been illustrated at Actelion Pharmaceuticals' annual general meeting this week. 60.2% of votes cast opposed the Swiss firm's compensation report for last year, while only 38.6% endorsed it. However, the company insists that the vote reflects a historical reality and that it has already made changes to future plans that will meet with shareholder approval.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts